We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

15 hedge funds and large institutions have $525K invested in Clovis Oncology, Inc. in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

85% less funds holding

Funds holding: 103 → 15 (-88)

98% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 90

99% less capital invested

Capital invested by funds: $42.9M → $525K (-$42.4M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
15
Holders Change
-88
Holders Change %
-85.44%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
90
Calls
$22K
Puts
–
Net Calls
+$22K
Net Calls Change
-$2.59M

Top Buyers

Rank Fund Capital Flow
1
STB
S&T Bank
Pennsylvania
+$13.2K
2
IA
IFP Advisors
Florida
+$33

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$12.1M
2
PAI
Palo Alto Investors
California
-$5.32M
3
BlackRock
BlackRock
New York
-$4.8M
4
QF
QVT Financial
New York
-$4.2M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
– -$547K -459,299 Closed
GCP
27
GSA Capital Partners
United Kingdom
– -$475K -399,039 Closed
IC
28
Ikarian Capital
Texas
– -$430K -361,518 Closed
Marshall Wace
29
Marshall Wace
United Kingdom
– -$370K -310,123 Closed
Northern Trust
30
Northern Trust
Illinois
– -$326K -273,233 Closed
GI
31
GAMCO Investors
Connecticut
– -$173K -145,400 Closed
Goldman Sachs
32
Goldman Sachs
New York
– -$166K -139,904 Closed
Barclays
33
Barclays
United Kingdom
– -$158K -132,775 Closed
Citadel Advisors
34
Citadel Advisors
Florida
– -$155K -129,979 Closed
XT
35
XTX Topco
Cayman Islands
– -$147K -123,853 Closed
HCM
36
Hollencrest Capital Management
California
– -$143K -120,000 Closed
SFI
37
Susquehanna Fundamental Investments
Pennsylvania
– -$137K -115,299 Closed
LSA
38
Leonteq Securities AG
Switzerland
– -$136K -114,500 Closed
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
– -$136 -111,750 Closed
GF
40
Gabelli Funds
New York
– -$132K -110,900 Closed
Principal Financial Group
41
Principal Financial Group
Iowa
– -$123K -103,638 Closed
VVM
42
Versant Venture Management
California
– -$121K -101,855 Closed
Bank of New York Mellon
43
Bank of New York Mellon
New York
– -$117K -97,995 Closed
T. Rowe Price Associates
44
T. Rowe Price Associates
Maryland
– -$103K -85,900 Closed
Wells Fargo
45
Wells Fargo
California
– -$96K -80,284 Closed
Cambridge Investment Research Advisors
46
Cambridge Investment Research Advisors
Iowa
– -$73K -61,667 Closed
PWM
47
Perigon Wealth Management
California
– -$73K -61,093 Closed
WA
48
WealthTrust Axiom
Pennsylvania
– -$71K -60,000 Closed
Charles Schwab
49
Charles Schwab
California
– -$70K -58,000 Closed
VF
50
Virtu Financial
New York
– -$64K -53,447 Closed
1
2
3 4

CLVS Hedge Fund Activity: Q4 2022 in Review

15 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q4 2022, worth a combined $525K — down 99% from $42.9M a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of CLVS and 2 opened new positions — a net loss of 88 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was S&T Bank, adding an estimated $13.2K. The largest seller was Vanguard Group, exiting entirely with an estimated $12.1M sold.

  • 15 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q4 2022, down from 103 in Q3 2022.
  • Funds reported $525K of Clovis Oncology, Inc. stock for Q4 2022, down 99% quarter-over-quarter.
  • 2 funds opened new Clovis Oncology, Inc. positions in Q4 2022 and 90 closed out, a net change of -88 holders.
  • The largest Clovis Oncology, Inc. buyer in Q4 2022 was S&T Bank, an estimated $13.2K added.
  • The largest Clovis Oncology, Inc. seller in Q4 2022 was Vanguard Group, an estimated $12.1M sold.

Based on aggregated 13F filings for Q4 2022.